Home News NAFDAC Hosts Côte d’Ivoire Drug Regulatory Agency on WHO Benchmarking Visit

NAFDAC Hosts Côte d’Ivoire Drug Regulatory Agency on WHO Benchmarking Visit

0
NAFDAC Hosts Côte d’Ivoire Drug Regulatory Agency on WHO Benchmarking Visit

 

The National Agency for Food and Drug Administration and Control (NAFDAC) is hosting a delegation from the Autorité Ivoirienne de Régulation Pharmaceutique (AIRP) of Côte d’Ivoire as part of a benchmarking visit aimed at strengthening the country’s preparedness for the World Health Organization (WHO) Global Benchmarking Tool (GBT) assessment toward attaining Maturity Level 3 (ML3).

 

The seven-day technical engagement is designed to provide AIRP officials with firsthand experience of NAFDAC’s regulatory systems, operational procedures, and best practices across key regulatory functions.

The benchmarking programme includes technical sessions on clinical trials oversight, market surveillance and control, and the national regulatory system, with a focus on NAFDAC’s Quality Management System (QMS).

Through presentations, technical discussions, and site visits, the visiting delegation is gaining practical insights into NAFDAC’s implementation of WHO GBT requirements, regulatory decision-making processes, post-market surveillance, Good Clinical Practice inspections, risk-based regulation, digitalisation, and quality management systems.

The visit highlights NAFDAC’s growing role as a regional centre of regulatory excellence following its attainment and sustained maintenance of WHO Maturity Level 3 status. It also reflects the agency’s commitment to promoting regulatory harmonisation, capacity building, and knowledge sharing among National Regulatory Authorities across the ECOWAS region to strengthen public health systems and improve access to safe, quality, and effective medical products.